Insider Trading & Ownership - Jay R. Luly, Ph.D.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Jay R. Luly, Ph.D.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2025-02-12
Purchase
2025-02-12
8:09 pm
ENANTA PHARMACEUTICALS INC ENTA Luly Jay R.
President and CEO
45,000 $5.69 $256,050 846,638
(Direct)
View
2024-12-06
Sale
2024-12-10
4:55 pm
ENANTA PHARMACEUTICALS INC ENTA Luly Jay R.
President and CEO
5,142 $8.06 $41,445 801,638
(Direct)
View
2023-12-05
Sale
2023-12-06
8:17 pm
ENANTA PHARMACEUTICALS INC ENTA Luly Jay R.
President and CEO
7,230 $9.63 $69,625 806,793
(Direct)
View
2023-03-13
Sale
2023-03-14
6:26 pm
ENANTA PHARMACEUTICALS INC ENTA Luly Jay R.
President and CEO
27,912 $45.16 $1,260,628 819,810
(Direct)
View
2022-12-16
Sale
2022-12-16
9:44 pm
ENANTA PHARMACEUTICALS INC ENTA Luly Jay R.
President and CEO
30,000 $44.72 $1,341,713 801,717
(Direct)
View
2021-09-15
Sale
2021-09-17
5:17 pm
ENANTA PHARMACEUTICALS INC ENTA Luly Jay R.
President and CEO
4,516 $59.06 $266,698 676,972
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2025-02-12
Tax Withholding
2025-02-14
4:35 pm
N/A
N/A
ENANTA PHARMACEUTICALS INC ENTA Luly Jay R.
President and CEO
7,484 $5.59 864,654
(Direct)
View
2025-02-12
Option Award
2025-02-14
4:35 pm
N/A
N/A
ENANTA PHARMACEUTICALS INC ENTA Luly Jay R.
President and CEO
25,500 $0 864,654
(Direct)
View
2024-12-01
Tax Withholding
2024-12-03
6:28 pm
N/A
N/A
ENANTA PHARMACEUTICALS INC ENTA Luly Jay R.
President and CEO
3,829 $8.6 806,780
(Direct)
View
2024-11-27
Option Award
2024-11-27
4:59 pm
N/A
2034-11-27
ENANTA PHARMACEUTICALS INC ENTA Luly Jay R.
President and CEO
250,000 $0 250,000
(Direct)
View
2024-02-12
Tax Withholding
2024-02-14
8:00 pm
N/A
N/A
ENANTA PHARMACEUTICALS INC ENTA Luly Jay R.
President and CEO
1,584 $12.41 810,609
(Direct)
View
2024-02-12
Option Award
2024-02-14
8:00 pm
N/A
N/A
ENANTA PHARMACEUTICALS INC ENTA Luly Jay R.
President and CEO
5,400 $0 810,609
(Direct)
View
2023-12-01
Tax Withholding
2023-12-05
9:08 pm
N/A
N/A
ENANTA PHARMACEUTICALS INC ENTA Luly Jay R.
President and CEO
5,787 $9.49 814,023
(Direct)
View
2023-11-22
Option Award
2023-11-22
5:10 pm
N/A
2033-11-22
ENANTA PHARMACEUTICALS INC ENTA Luly Jay R.
President and CEO
264,000 $0 264,000
(Direct)
View
2023-03-13
Exercise
2023-03-14
6:26 pm
N/A
2023-03-21
ENANTA PHARMACEUTICALS INC ENTA Luly Jay R.
President and CEO
27,912 $0 819,810
(Direct)
View
2023-03-13
Exercise
2023-03-14
6:26 pm
N/A
N/A
ENANTA PHARMACEUTICALS INC ENTA Luly Jay R.
President and CEO
27,912 $14 819,810
(Direct)
View
2023-02-13
Tax Withholding(A)
2023-02-15
9:42 pm
N/A
N/A
ENANTA PHARMACEUTICALS INC ENTA Luly Jay R.
President and CEO
20,591 $52.77 819,810
(Direct)
View
2023-02-13
Option Award(A)
2023-02-15
9:42 pm
N/A
N/A
ENANTA PHARMACEUTICALS INC ENTA Luly Jay R.
President and CEO
52,096 $0 819,810
(Direct)
View
2023-02-13
Tax Withholding
2023-02-15
8:56 pm
N/A
N/A
ENANTA PHARMACEUTICALS INC ENTA Luly Jay R.
President and CEO
20,591 $52.77 799,219
(Direct)
View
2023-02-13
Option Award
2023-02-15
8:56 pm
N/A
N/A
ENANTA PHARMACEUTICALS INC ENTA Luly Jay R.
President and CEO
31,505 $0 799,219
(Direct)
View
2022-12-19
Exercise
2022-12-19
7:50 pm
N/A
2023-12-05
ENANTA PHARMACEUTICALS INC ENTA Luly Jay R.
President and CEO
14,500 $0 843,805
(Direct)
View
2022-12-19
Exercise
2022-12-19
7:50 pm
N/A
N/A
ENANTA PHARMACEUTICALS INC ENTA Luly Jay R.
President and CEO
14,500 $27.58 843,805
(Direct)
View
2022-12-16
Exercise
2022-12-16
9:44 pm
N/A
2022-12-26
ENANTA PHARMACEUTICALS INC ENTA Luly Jay R.
President and CEO
30,000 $0 801,717
(Direct)
View
2022-12-16
Exercise
2022-12-16
9:44 pm
N/A
N/A
ENANTA PHARMACEUTICALS INC ENTA Luly Jay R.
President and CEO
13,851 $14 801,717
(Direct)
View
2022-12-16
Exercise
2022-12-16
9:44 pm
N/A
N/A
ENANTA PHARMACEUTICALS INC ENTA Luly Jay R.
President and CEO
16,149 $14.18 801,717
(Direct)
View
2022-12-01
Tax Withholding
2022-12-05
7:17 pm
N/A
N/A
ENANTA PHARMACEUTICALS INC ENTA Luly Jay R.
President and CEO
5,659 $44.33 773,805
(Direct)
View
2022-11-23
Option Award
2022-11-28
6:17 pm
N/A
2032-11-23
ENANTA PHARMACEUTICALS INC ENTA Luly Jay R.
President and CEO
197,000 $0 913,464
(Direct)
View
2022-02-14
Tax Withholding
2022-02-15
9:32 pm
N/A
N/A
ENANTA PHARMACEUTICALS INC ENTA Luly Jay R.
President and CEO
2,355 $62.49 716,464
(Direct)
View
2022-02-14
Option Award
2022-02-15
9:32 pm
N/A
N/A
ENANTA PHARMACEUTICALS INC ENTA Luly Jay R.
President and CEO
8,028 $0 716,464
(Direct)
View
2022-01-15
Exercise
2022-01-18
06:04 am
N/A
N/A
ENANTA PHARMACEUTICALS INC ENTA Luly Jay R.
President and CEO
10,063 $11.77 710,791
(Direct)
View
2022-01-15
Exercise
2022-01-18
06:04 am
N/A
2022-06-20
ENANTA PHARMACEUTICALS INC ENTA Luly Jay R.
President and CEO
10,063 $0 710,791
(Direct)
View
2021-12-01
Tax Withholding
2021-12-03
6:33 pm
N/A
N/A
ENANTA PHARMACEUTICALS INC ENTA Luly Jay R.
President and CEO
1,944 $87.68 700,728
(Direct)
View
2021-11-19
Option Award
2021-11-23
7:23 pm
N/A
2031-11-19
ENANTA PHARMACEUTICALS INC ENTA Luly Jay R.
President and CEO
133,500 $0 810,472
(Direct)
View
2020-12-15
Exercise
2020-12-16
6:20 pm
N/A
N/A
ENANTA PHARMACEUTICALS INC ENTA Luly Jay R.
President and CEO
7,500 $0 681,488
(Direct)
View
2020-12-15
Tax Withholding
2020-12-16
6:20 pm
N/A
N/A
ENANTA PHARMACEUTICALS INC ENTA Luly Jay R.
President and CEO
2,201 $42.52 681,488
(Direct)
View
2020-11-20
Option Award
2020-11-20
8:21 pm
N/A
2030-11-20
ENANTA PHARMACEUTICALS INC ENTA Luly Jay R.
President and CEO
134,300 $0 783,989
(Direct)
View
(A) Indicate amendment filing.